Management of Symptomatic Urinary Tract Infection in Pregnancy

Diagnostic Approach

• Obtain a urine culture before initiating antibiotics in any pregnant woman with UTI symptoms – the European Association of Urology (EAU) recommends mandatory culture‑directed therapy because pregnancy alters the risk‑benefit balance of empiric treatment. 1
• Pregnancy is a specific complicating factor that necessitates culture‑guided antibiotic selection; this ensures appropriate drug choice and confirms microbiologic eradication. 1

First‑Line Antibiotic Regimens

Nitrofurantoin

• Dose: 100 mg orally twice daily for 5 days. The EAU lists this regimen as a preferred option for uncomplicated cystitis in pregnancy. 1
• Safety limitation: Nitrofurantoin should be avoided in the third trimester (after 36 weeks) because of the risk of neonatal hemolytic anemia. (Praxis Medical Insights) 3

Fosfomycin Trometamol

• Dose: Single oral dose of 3 g. Supported by the EAU as an effective, single‑dose regimen throughout pregnancy. 1
• Efficacy note: Clinical Infectious Diseases (IDSA) data indicate that fosfomycin may have slightly lower cure rates than multi‑day regimens but offers superior adherence due to its convenience. 5

Third‑Generation Cephalosporins

• Options: Cefixime or ceftibuten (3‑day course). The EAU recommends these agents because of high susceptibility of E. coli (the predominant uropathogen) and an excellent safety profile in pregnancy. 1

Alternative Agents

• Beta‑lactams (e.g., amoxicillin‑clavulanate, cephalexin) are acceptable when first‑line drugs cannot be used, though they demonstrate modestly lower efficacy compared with nitrofurantoin or fosfomycin. 2
• Trimethoprim‑sulfamethoxazole should be avoided in the first and third trimesters (risk of neural‑tube defects and kernicterus, respectively). It may be considered in the second trimester only if local resistance rates are <20 % and the isolate is susceptible. 2

Treatment Duration and Follow‑Up

• Standard course for symptomatic cystitis: 5–7 days of therapy, as advised by the EAU. 1
• Post‑treatment monitoring: Pregnant patients should undergo periodic urine cultures after therapy to detect recurrent bacteriuria. (Praxis Medical Insights) 6
• Persistent symptoms (>7 days): Obtain a repeat urine culture and susceptibility testing before prescribing additional antibiotics. (Praxis Medical Insights) 6

Management of Acute Pyelonephritis in Pregnancy

• Hospitalization and parenteral therapy are typically required; recommended IV options include amoxicillin + aminoglycoside, ceftriaxone 1–2 g daily, or carbapenems. (Infectious Diseases Society of America – IDSA) 7
• Total treatment duration: 10–14 days, with a switch to oral agents once the patient is afebrile and clinically stable. (IDSA) 7
• Nitrofurantoin is contraindicated for pyelonephritis because of poor tissue penetration. (Praxis Medical Insights) 3

Critical Pitfalls to Avoid

• Fluoroquinolones must not be used in pregnancy due to documented cartilage toxicity in the developing fetus. (IDSA) 7
• Do not omit urine culture even when classic UTI symptoms are present; culture confirmation is mandatory in pregnancy. 1
• Screening and treatment of asymptomatic bacteriuria remain standard: a single first‑trimester screen‑and‑treat approach with a short‑course regimen is recommended by the EAU. 1

All statements are based on guideline‑level evidence where available; specific strength of recommendation was not explicitly detailed in the source documents.